The Assessment of Platelet Activation in Antiplatelet Drug Development

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|12|26|3117-3125

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.12, Iss.26, 2005-12, pp. : 3117-3125

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Relationship Between Inflammation, Platelet Activation and Antiplatelet Resistance

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 9, Iss. 5, 2010-12 ,pp. : 364-381

Bentham Science Publishers

Access to resources Recommend Favorite

Platelet Activation, and Antiplatelet Targets and Agents: Current and Novel Strategies

By Xiang Yao-Zu   Xia Ye   Gao Xiu-Mei   Shang Hong-Cai   Kang Li-Yuan   Zhang Bo-Li  

Drugs, Vol. 68, Iss. 12, 2008-01 ,pp. : 1647-1664

Adis International

Access to resources Recommend Favorite

Polyphenols: Anti-Platelet Nutraceutical?

By  

Current Pharmaceutical Design, Vol. 24, Iss. 2, 2018-04 ,pp. : 146-157

Bentham Science Publishers

Access to resources Recommend Favorite

Genetics in Anti-Platelet Treatment

By  

Current Pharmaceutical Design, Vol. 22, Iss. 29, 2016-09 ,pp. : 4506-4511

Bentham Science Publishers

Access to resources Recommend Favorite

Risk Assessment in Drug Development: Autoimmunity

By Hastings Kenneth  

Journal of Toxicology and Environmental Health, Vol. 69, Iss. 9, 2006-05 ,pp. : 893-898

Taylor & Francis Ltd

Access to resources Recommend Favorite